Cite
HARVARD Citation
Schjesvold, F. et al. (2021). Isatuximab plus pomalidomide and dexamethasone in frail patients with relapsed/refractory multiple myeloma: ICARIA‐MM subgroup analysis. American journal of hematology. 96 (11), pp. E423-E427. [Online].